Actively Recruiting
The Efficacy of Intradermal Acupuncture for Ocular Surface Diseases After Intractable Facial Paralysis
Led by The First Affiliated Hospital of Zhejiang Chinese Medical University · Updated on 2026-04-17
78
Participants Needed
1
Research Sites
103 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to explore the clinical efficacy of intradermal acupuncture in the treatment of ocular surface diseases after Intractable Facial Paralysis, and to seek effective and convenient treatment for ocular surface diseases after intractable peripheral facial paralysis. The main question it aims to answer is ： Will the intradermal acupuncture intervention effectively reduce the OSDI score ? The researchers compared the intradermal acupuncture with the placebo-needle to observe whether the intradermal acupuncture could better improve the symptoms.
CONDITIONS
Official Title
The Efficacy of Intradermal Acupuncture for Ocular Surface Diseases After Intractable Facial Paralysis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female patients aged 18 to 65 years
- Diagnosed with intractable peripheral facial paralysis lasting from 1 month to 1 year
- Facial nerve grading system (FNGS) 2.0 score of 15 or higher; electroneurography (ENoG) shows compound muscle action potential amplitude ratio of 20% or less
- At least one eye symptom such as dryness, foreign body sensation, burning, fatigue, redness, or fluctuating vision
- Ocular surface disease index (OSDI) scores between 30 and 80
- Voluntarily provide written informed consent and able to comply with treatment and follow-up
You will not qualify if you...
- Other eye diseases including glaucoma, keratitis, retinopathy, or acute inflammation of the conjunctiva, sclera, or cornea
- Eye surgery or laser therapy within the past 90 days
- Use of systemic or topical antibiotics or medications affecting tears within the past 3 weeks; use of dry eye medications within 2 weeks
- Lacrimal passage blockage, dacryocystitis, punctal occlusion, or neurological problems preventing full eyelid closure
- Blood clotting disorders, open wounds, or local infections at treatment sites
- Allergy to materials used in the needles or adhesive tape
- Pregnancy or breastfeeding
- Severe heart, liver, kidney, psychiatric conditions, or cancer
- Participation in another clinical trial within the past month
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Hangzhou, Zhejiang, China, 310000
Actively Recruiting
Research Team
B
Binyan Yu Binyan Yu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here